Newlat Food S.p.A. shares have been in strong demand lately. The technical chart pattern looks positive which may give rise to new gains. Investors have an opportunity to buy the stock and target the € 6.5.
Summary
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.
Strengths
Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 64% by 2022.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.47 for the 2020 fiscal year.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For the past twelve months, EPS forecast has been revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
Disclaimer:
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.